How big is the Canada Self-Monitoring Blood Glucose Market?

The Canada Self-Monitoring Blood Glucose Market size is expected to reach USD 391.84 million in 2024 and grow at a CAGR of 6.71% to reach USD 542.16 million by 2029. Read More

What is the current Canada Self-Monitoring Blood Glucose Market size?

In 2024, the Canada Self-Monitoring Blood Glucose Market size is expected to reach USD 391.84 million. Read More

Who are the key players in Canada Self-Monitoring Blood Glucose Market?

Abbott Diabetes Care, Roche Diabetes Care, Ascensia Diabetes Care, LifeScan, Inc. and Arkray, Inc. are the major companies operating in the Canada Self-Monitoring Blood Glucose Market. Read More

What years does this Canada Self-Monitoring Blood Glucose Market cover, and what was the market size in 2023?

In 2023, the Canada Self-Monitoring Blood Glucose Market size was estimated at USD 367.20 million. The report covers the Canada Self-Monitoring Blood Glucose Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Canada Self-Monitoring Blood Glucose Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Canada Self-Monitoring Blood Glucose Market Share

Statistics for the 2023 & 2024 Canada Self-Monitoring Blood Glucose market share, created by Mordor Intelligence™ Industry Reports. Canada Self-Monitoring Blood Glucose share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Canada Self-Monitoring Blood Glucose Industry

The Canadian self-monitoring blood glucose market is moderately fragmented, with a few significant and other generic players. Manufacturers like Abbott, LifeScan, F. Hoffmann-La Roche AG, and Ascensia occupy a major share.